Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hanke

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Ebiomedicine|July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccinationClara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
European Journal of Medicinal Chemistry|August 29, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1Theresa E Mensing, Christian G Kurz, Jennifer A Amrhein, et al.
European Journal of Medicinal Chemistry|April 24, 2023
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamilyMarcel Rak, Roberta Tesch, Lena M Berger, et al.
Journal of Medicinal Chemistry|July 19, 2024
Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase InhibitorsJoshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activityJoshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Journal of Medicinal Chemistry|February 29, 2024
Development of Selective Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one-Based Mammalian STE20-Like (MST3/4) Kinase InhibitorsMarcel Rak, Amelie Menge, Roberta Tesch, et al.
European Journal of Medicinal Chemistry|July 28, 2018
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E<sub>2</sub> synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammationSun-Yee Cheung, Markus Werner, Lucia Esposito, et al.
Journal of Medicinal Chemistry|January 23, 2026
Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC DiscoveryMarko Mitrović, Francesco Aleksy Greco, Yiliam Cruz García, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)Martina Dettenhöfer, Laura Nadine Tandara, Jennifer Alisa Amrhein, et al.
ACS Chemical Biology|April 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 InhibitorSebastian Mandel, Thomas Hanke, Sebastian Mathea, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Ebiomedicine|July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccinationClara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
European Journal of Medicinal Chemistry|August 29, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1Theresa E Mensing, Christian G Kurz, Jennifer A Amrhein, et al.
European Journal of Medicinal Chemistry|April 24, 2023
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamilyMarcel Rak, Roberta Tesch, Lena M Berger, et al.
Journal of Medicinal Chemistry|July 19, 2024
Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase InhibitorsJoshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activityJoshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Journal of Medicinal Chemistry|February 29, 2024
Development of Selective Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one-Based Mammalian STE20-Like (MST3/4) Kinase InhibitorsMarcel Rak, Amelie Menge, Roberta Tesch, et al.
European Journal of Medicinal Chemistry|July 28, 2018
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E<sub>2</sub> synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammationSun-Yee Cheung, Markus Werner, Lucia Esposito, et al.
Journal of Medicinal Chemistry|January 23, 2026
Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC DiscoveryMarko Mitrović, Francesco Aleksy Greco, Yiliam Cruz García, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)Martina Dettenhöfer, Laura Nadine Tandara, Jennifer Alisa Amrhein, et al.
ACS Chemical Biology|April 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 InhibitorSebastian Mandel, Thomas Hanke, Sebastian Mathea, et al.
Pageof 11